FDA.reportPublic FDA data

inFLIXimab-axxq 100 MG Injection

RxCUI
2266525
RxNorm name
inFLIXimab-axxq 100 MG Injection
Display name
inFLIXimab-axxq 100 MG Injection
Full name
inFLIXimab-axxq 100 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761086Avsolainfliximab-axxq351(k) BiosimilarRx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
de34bcb7-b524-45c8-9181-61c6f48d540einFLIXimab-axxq 100 MG InjectionPSN18These highlights do not include all the information needed to use AVSOLA ® safely and effectively. See full prescribing information for AVSOLA. AVSOLA (infliximab-axxq) for injection, for intravenous use Initial U.S. Approval: 2019 AVSOLA (infliximab-axxq) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwe20250908
de34bcb7-b524-45c8-9181-61c6f48d540einfliximab-axxq 100 MG InjectionSCD18These highlights do not include all the information needed to use AVSOLA ® safely and effectively. See full prescribing information for AVSOLA. AVSOLA (infliximab-axxq) for injection, for intravenous use Initial U.S. Approval: 2019 AVSOLA (infliximab-axxq) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwe20250908